Naxagolide
Naxagolide[edit | edit source]
Naxagolide is a chemical compound that was investigated for its potential use as a dopamine receptor agonist. It is structurally related to other dopaminergic agents and was primarily researched for its effects on the central nervous system.
Chemical Properties[edit | edit source]
Naxagolide is a synthetic compound with a complex chemical structure. It belongs to the class of ergoline derivatives, which are known for their activity on dopamine receptors. The chemical structure of Naxagolide includes a tetracyclic ergoline skeleton, which is characteristic of many compounds with dopaminergic activity.
Pharmacology[edit | edit source]
Naxagolide acts as a potent agonist at the dopamine D2 receptor, which is a subtype of dopamine receptor involved in various neurological processes. By stimulating these receptors, Naxagolide can influence motor control, mood, and other functions regulated by the dopaminergic system.
Mechanism of Action[edit | edit source]
The primary mechanism of action of Naxagolide involves the activation of dopamine D2 receptors. This activation can lead to increased dopaminergic activity in the brain, which is beneficial in conditions where dopamine levels are deficient, such as Parkinson's disease.
Clinical Research[edit | edit source]
Naxagolide was studied for its potential therapeutic effects in treating Parkinson's disease and other disorders characterized by dopaminergic dysfunction. However, despite its promising pharmacological profile, Naxagolide did not progress to widespread clinical use.
Potential Applications[edit | edit source]
While Naxagolide itself is not used clinically, research into its structure and activity has contributed to the development of other dopaminergic agents. Understanding the interaction of Naxagolide with dopamine receptors has provided insights into designing new drugs with improved efficacy and safety profiles.
Related Compounds[edit | edit source]
Naxagolide is related to other ergoline derivatives, such as bromocriptine and cabergoline, which are used in clinical practice for their dopaminergic effects. These compounds share a similar mechanism of action and are used in the treatment of conditions like Parkinson's disease and hyperprolactinemia.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
